AXIN2 expression was also rescued as well as β-catenin using α-solanine, effectively reversing the bone morphogenetic protein receptor type-2 (BMPR2) downregulation in the PAH model. The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.